Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/253433
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Título

Biological Profiling of Semisynthetic C19-Functionalized Ferruginol and Sugiol Analogues

AutorGonzález-Cardenete, Miguel A. CSIC ORCID ; Rivas, Fátima; Bassett, Rachel; Stadler, Marco; Hering, Steffen; Padrón, José M.; Zaragozá, Ramón José; Dea-Ayuela, M. Auxiliadora
Fecha de publicación12-feb-2021
EditorMultidisciplinary Digital Publishing Institute
CitaciónAntibiotics 10(2): 184 (2021)
ResumenThe abietane-type diterpenoids are significant bioactive compounds exhibiting a varied range of pharmacological properties. In this study, the first synthesis and biological investigation of the new abietane-diterpenoid (+)-4-epi-liquiditerpenoid acid (8a) together with several of its analogs are reported. The compounds were generated from the readily available methyl callitrisate (7), which was obtained from callitrisic acid present in Moroccan Sandarac resin. A biological evaluation was conducted to determine the effects of the different functional groups present in these molecules, providing basic structure¿activity relationship (SAR) elements. In particular, the ferruginol and sugiol analogs compounds 10¿16 were characterized by the presence of a phenol moiety, higher oxidization states at C-7 (ketone), and the hydroxyl, methyl ester or free carboxylic acid at C19. The biological profiling of these compounds was investigated against a panel of six human solid tumor cell lines (HBL-100, A549, HeLa, T-47D, SW1573 and WiDr), four parasitic Leishmania species (L. donovani, L. infantum, L. guyanensis and L. amazonensis) and two malaria strains (3D7 and K1). Furthermore, the capacity of the compounds to modulate gamma-aminobutyric acid type A (GABAA) receptors (alfa1beta2gamma2s) is also described. A comparison of the biological results with those previously reported of the corresponding C18-functionalized analogs was conducted.
Versión del editorhttp://dx.doi.org/10.3390/antibiotics10020184
URIhttp://hdl.handle.net/10261/253433
DOI10.3390/antibiotics10020184
Identificadoresdoi: 10.3390/antibiotics10020184
issn: 2079-6382
Aparece en las colecciones: (ITQ) Artículos




Ficheros en este ítem:
Fichero Descripción Tamaño Formato
848089.pdf487,25 kBUnknownVisualizar/Abrir
Mostrar el registro completo

CORE Recommender

PubMed Central
Citations

2
checked on 13-abr-2024

SCOPUSTM   
Citations

6
checked on 23-abr-2024

WEB OF SCIENCETM
Citations

4
checked on 23-feb-2024

Page view(s)

38
checked on 29-abr-2024

Download(s)

41
checked on 29-abr-2024

Google ScholarTM

Check

Altmetric

Altmetric


Artículos relacionados:


Este item está licenciado bajo una Licencia Creative Commons Creative Commons